Phenylephrine
treatment of clinically important hypotension resulting primarily from vasodilation in...
High-alert medication
- Adrenergic agonists, IV (class)
Indications
- treatment of clinically important hypotension resulting primarily from vasodilation in...
Adult dosing
- bolus hypotension: dose: 40; unit: mcg; route: IV; interval: 40 mcg to 100 mcg every 1-2 minutes as needed; fixed: true; labelExcerpt: Bolus intravenous injection: 40 mcg to 100 mcg every 1-2 minutes as needed, not to exceed 200 mcg.
- infusion hypotension: dose: 10; unit: mcg/min; route: IV; interval: 10 mcg/min to 35 mcg/min; fixed: true; titrationTarget: Titrate to effect. titrating to effect; labelExcerpt: Intravenous infusion: 10 mcg/min to 35 mcg/min, titrating to effect, not to exceed 200 mcg/min.
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- failure: Consider starting at the lower end of the recommended dose range; note: In end stage renal disease (ESRD), dose-response data indicate increased responsiveness. Label: "In patients with end stage renal disease (ESRD), dose-response data indicate increased responsiveness to phenylephrine. Consider starting at the lower end of the recommended dose range, and adjusting dose based on the target b"
Hepatic adjustment
- In patients with liver cirrhosis [Child Pugh Class B and Class C], start dosing in the recommended dose range, but more phenylephrine may be needed.
Contraindications
- None
Clinical pearls
- Dilute before administration for bolus or infusion.
- Correct intravascular volume depletion and acidosis prior to administration.
- Extravasation may cause necrosis or sloughing; ensure free flow at the infusion site.
- Monitor for bradycardia and decreased cardiac output.
Source and review
- DailyMed label (phenylephrine hydrochloride), Set ID 4cea0781-2513-4030-8568-62dec253f866, effective 2026-10-17. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties